Biogen Inc (NASDAQ:BIIB)
| 289.35 BATS BZX Real-Time Price As of 3:50pm ET |  -6.47 / -2.19%Today’s Change | 223.25 Today|||52-Week Range 468.55 | +18.17% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 295.82 |
| Today’s open | 288.65 |
| Day’s range | 287.27 - 292.00 |
| Volume | 56,841 |
| Average volume (3 months) | 1,712,772 |
| Market cap | $44.7B |
Data as of 3:50pm ET, 09/22/2021
Growth & Valuation
| Earnings growth (last year) | -21.00% |
| Earnings growth (this year) | -44.75% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | -2.82% |
| P/E ratio | 22.5 |
| Price/Sales | 3.20 |
| Price/Book | 4.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -0.61 | -0.14% |
| TECHBio-Techne Corp | +0.22 | +0.04% |
| ---- | ||
| EXASExact Sciences Corp | -2.67 | -2.53% |
Data as of 3:50pm ET, 09/22/2021
Financials
| Next reporting date | October 26, 2021 |
| EPS forecast (this quarter) | $4.16 |
| Annual revenue (last year) | $12.4B |
| Annual profit (last year) | $4.0B |
| Net profit margin | 32.38% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
